V. Chouraki, G. Savoye, L. Dauchet, G. Vernier-massouille, J. Dupas et al., The changing pattern of Crohn's disease incidence in northern France: a continuing increase in the 10-to 19-year- old age bracket Alimentary pharmacology & therapeutics, pp.1133-4215, 1988.

S. Kugathasan, R. Judd, R. Hoffmann, J. Heikenen, G. Telega et al., Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease in wisconsin: a statewide population-based study, The Journal of Pediatrics, vol.143, issue.4, pp.525-556, 2003.
DOI : 10.1067/S0022-3476(03)00444-X

H. Hildebrand, Y. Finkel, L. Grahnquist, J. Lindholm, A. Ekbom et al., Changing pattern of paediatric inflammatory bowel disease in northern Stockholm, Gut, vol.5213, issue.10, pp.1432-1436, 1990.

B. Hope, R. Shahdadpuri, C. Dunne, A. Broderick, T. Grant et al., Rapid rise in incidence of Irish paediatric inflammatory bowel disease, Archives of Disease in Childhood, vol.97, issue.7, pp.590-594, 2012.
DOI : 10.1136/archdischild-2011-300651

A. Griffiths, P. Nguyen, C. Smith, J. Macmillan, and P. Sherman, Growth and clinical course of children with Crohn's disease., Gut, vol.34, issue.7, pp.939-4301, 1993.
DOI : 10.1136/gut.34.7.939

M. Pfefferkorn, G. Burke, A. Griffiths, J. Markowitz, J. Rosh et al., Growth Abnormalities Persist in Newly Diagnosed Children With Crohn Disease Despite Current Treatment Paradigms, Journal of Pediatric Gastroenterology and Nutrition, vol.48, issue.2, pp.168-7431, 2009.
DOI : 10.1097/MPG.0b013e318175ca7f

F. Vasseur, C. Gower-rousseau, G. Vernier-massouille, J. Dupas, V. Merle et al., Nutritional status and growth in pediatric Crohn's disease: a population-based study. The American journal of gastroenterology, pp.1893-90002, 2010.

A. Sawczenko, A. Ballinger, M. Savage, and I. Sanderson, Clinical Features Affecting Final Adult Height in Patients With Pediatric-Onset Crohn's Disease, PEDIATRICS, vol.118, issue.1, pp.124-905, 2006.
DOI : 10.1542/peds.2005-2931

J. Markowitz, K. Grancher, J. Rosa, H. Aiges, and F. Daum, Growth Failure in Pediatric Inflammatory Bowel Disease, Journal of Pediatric Gastroenterology and Nutrition, vol.16, issue.4, pp.373-80, 1993.
DOI : 10.1097/00005176-199305000-00005

H. Hildebrand, J. Karlberg, and B. Kristiansson, Longitudinal Growth in Children and Adolescents with Inflammatory Bowel Disease, Journal of Pediatric Gastroenterology and Nutrition, vol.18, issue.2, pp.165-7301, 1994.
DOI : 10.1097/00005176-199402000-00008

J. Satsangi, M. Silverberg, S. Vermeire, J. Colombel, A. Levine et al., The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification Natural history of pediatric Crohn's disease: a population-based cohort study, Gut. Inflammatory bowel diseases. Gastroenterology, vol.55161713512, issue.1264, pp.749-531314, 2006.

B. Pigneur, P. Seksik, S. Viola, J. Viala, L. Beaugerie et al., Natural history of Crohn's disease: comparison between childhood-and adult-onset disease The natural history of adult Crohn's disease in population-based cohorts. The American journal of gastroenterology, Inflammatory bowel diseases, vol.1610510, issue.62, pp.953-61289, 2009.

B. Pariente, J. Cosnes, S. Danese, W. Sandborn, M. Lewin et al., Hanauer SB, Stromberg U. Oral Pentasa in the treatment of active Crohn's disease: A metaanalysis of double-blind, placebo-controlled trials Traditional corticosteroids for induction of remission in Crohn's disease. Cochrane database of systematic reviews (Online) The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations Immediate and longterm outcomes of corticosteroid therapy in pediatric Crohn's disease patients Inflammatory bowel disease: clinical aspects and established and evolving therapies Evaluation of oral budesonide for treatment of mild and moderate exacerbations of Crohn's disease in children Budesonide for induction of remission in Crohn's disease Cochrane database of systematic reviews (Online), disease digestive damage score, the Lemann score, pp.1415-22379, 2002.

O. Borrelli, L. Cordischi, M. Cirulli, M. Paganelli, V. Labalestra et al., Polymeric diet alone versus corticosteroids in the treatment of active pediatric Crohn's disease: a randomized controlled open-label trial. Clinical gastroenterology and hepatology : the official clinical practice journal of the Meta-analysis: enteral nutrition in active Crohn's disease in children, American Gastroenterological Association. Epub Alimentary pharmacology & therapeutics, vol.426, issue.66, pp.744-53795, 2006.

N. Afzal, S. Davies, M. Paintin, F. Arnaud-battandier, J. Walker-smith et al., Colonic Crohn's disease in children does not respond well to treatment with enteral nutrition if the ileum is not involved Digestive diseases and sciences Longer-term outcomes of nutritional management of Crohn's disease in children. Digestive diseases and sciences Enteral nutritional therapy for induction of remission in Crohn's disease. Cochrane database of systematic reviews (Online) 2007(1):CD000542. Epub Interventions for growth failure in childhood Crohn's disease. Cochrane database of systematic reviews (Online) Natural history of Crohn's disease in a population-based cohort from Cardiff): a study of changes in medical treatment and surgical resection rates, CD003873. Epub 2005/07/22. 30. Ramadas AV, pp.1471-52171, 1986.

J. Ezri, P. Marques-vidal, A. Nydegger, A. Rubio, B. Pigneur et al., Impact of disease and treatments on growth and puberty of pediatric patients with inflammatory bowel disease The efficacy of exclusive nutritional therapy in paediatric Crohn's disease, comparing fractionated oral vs. continuous enteral feeding Prevention of relapse by mesalazine (Pentasa) in pediatric Crohn's disease: a multicenter, double-blind, randomized, placebo-controlled trial, Digestion. Alimentary pharmacology & therapeutics. Epub Gastroenterologie clinique et biologique, vol.8513332233, issue.33101, pp.308-191332, 2009.

S. Uhlen, R. Belbouab, K. Narebski, O. Goulet, J. Schmitz et al., Efficacy of methotrexate in pediatric Crohn's disease: a French multicenter study Review article: diet and inflammatory bowel disease--epidemiology and treatment Infliximab (REMICADE) therapy in the treatment of pediatric Crohn's disease. The American journal of gastroenterology, Inflammatory bowel diseases. Alimentary pharmacology & therapeutics, vol.12309810, issue.3524, pp.1053-799, 2003.

J. Hyams, T. Walters, W. Crandall, S. Kugathasan, A. Griffiths et al., Safety and efficacy of maintenance infliximab therapy for moderate-to-severe Crohn's disease in children: REACH openlabel extension. Current medical research and opinion, pp.651-62, 2011.

J. Hyams, W. Crandall, S. Kugathasan, A. Griffiths, A. Olson et al., Induction and Maintenance Infliximab Therapy for the Treatment of Moderate-to-Severe Crohn???s Disease in Children, Gastroenterology, vol.132, issue.3, pp.863-73, 2007.
DOI : 10.1053/j.gastro.2006.12.003

F. Ruemmele, A. Lachaux, J. Cezard, A. Morali, C. Maurage et al., Efficacy of infliximab in pediatric Crohn's disease: a randomized multicenter open-label trial comparing scheduled to on demand maintenance therapy Long-term outcome of maintenance infliximab therapy in children with Crohn's disease Safety and efficacy of adalimumab for moderate to severe Crohn's disease in children, Inflammatory bowel diseases. Inflammatory bowel diseases. Epub Gastroenterology, vol.1522151225143, issue.412, pp.388-94816, 2008.

B. Siat, . Ma, C. Vidailhet, F. Tenenbaum, J. Ruhland et al., Maladie de Crohn et rectocolite ulcéro-hémorragique de l'adolescent corrélations psychopathologiques. A propos de l'étude de 14 cas. Neuropsychiatrie de l'enfance et de l'adolescence-9):459-6. 43. Wolf A, Burnat P, Garcia-Hejl C, Ceppa F. [Pharmacological and pharmacogenetic study of two immunomodulators: azathioprine and 6-mercaptopurine. Strategies for preventing complications]. Gastroenterologie clinique et biologique, pp.176-8402, 1992.

E. Prefontaine, J. Macdonald, L. Sutherland, B. Korelitz, N. Wisch et al., Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease. Cochrane database of systematic reviews (Online) 2010(6):CD000545 Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study, The New England journal of medicine, vol.302, issue.18, pp.981-988, 1980.

E. Prefontaine, L. Sutherland, J. Macdonald, and M. Cepoiu, Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease. Cochrane database of systematic reviews (Online), Epub, vol.23, issue.101, p.67, 2009.

J. Markowitz, K. Grancher, N. Kohn, M. Lesser, F. Daum et al., A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease Tolerance and efficacy of azathioprine in pediatric Crohn's disease, Gastroenterology. Inflammatory bowel diseases, vol.11917, issue.410, pp.895-9022138, 2000.

. Infliximab, or combination therapy for Crohn's disease, The New England journal of medicine, vol.36216, issue.15, pp.1383-95, 2010.

J. Punati, J. Markowitz, T. Lerer, J. Hyams, S. Kugathasan et al., Effect of early immunomodulator use in moderate to severe pediatric Crohn disease, Inflammatory Bowel Diseases, vol.12, issue.7, pp.949-54, 2008.
DOI : 10.1097/00054725-200301000-00006

T. Lecomte, J. Contou, L. Beaugerie, F. Carbonnel, S. Cattan et al., Predictive factors of response of perianal Crohn's disease to azathioprine or 6-mercaptopurine. Diseases of the colon and rectum, pp.1469-75, 2003.

W. Jeshion, K. Larsen, A. Jawad, D. Piccoli, R. Verma et al., Azathioprine and 6-Mercaptopurine for the Treatment of Perianal Crohn's Disease in Children, Journal of Clinical Gastroenterology, vol.30, issue.3, pp.294-302, 2000.
DOI : 10.1097/00004836-200004000-00018

J. Cosnes, S. Cattan, A. Blain, L. Beaugerie, F. Carbonnel et al., Long-term evolution of disease behavior of Crohn's disease Has there been a change in the natural history of Crohn's disease? Surgical rates and medical management in a population-based inception cohort from Western Hungary between 1977-2009. The American journal of gastroenterology Impact of azathioprine and tumour necrosis factor antagonists on the need for surgery in newly diagnosed Crohn's disease, Inflammatory bowel diseases. Gut, vol.82010760, issue.5447, pp.244-50579, 2002.

6. Azathioprine, Y. Bouhnik, J. Mary, J. Colombel, B. Duclos et al., The American journal of gastroenterology Azathioprine withdrawal in patients with Crohn's disease maintained on prolonged remission: a high risk of relapse. Clinical gastroenterology and hepatology : the official clinical practice journal of the Review article: remission rates achievable by current therapies for inflammatory bowel disease. Alimentary pharmacology & therapeutics Adverse events of thiopurine immunomodulators in patients with inflammatory bowel disease. Gastroenterologia y hepatologia, American Gastroenterological Association. Epub, vol.104733183428, issue.596, pp.2089-9680, 2009.

B. Kirschner, W. Connell, M. Kamm, J. Ritchie, L. Colombel et al., Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy Thiopurine methyltransferase genotype predicts therapy-limiting severe toxicity from azathioprine Normal thiopurine methyltransferase levels do not eliminate 6-mercaptopurine or azathioprine toxicity in children with inflammatory bowel disease Guidelines for the Management of Inflammatory Bowel Disease in Children in the United Kingdom Drug Insight: pharmacology and toxicity of thiopurine therapy in patients with IBD. Nature clinical practice Gastroenterology & hepatology, Gastroenterology. Gut. Gastroenterology. Annals of internal medicine. Journal of clinical gastroenterology. Epub Journal of pediatric gastroenterology and nutrition, vol.115341181293030429, issue.67, pp.813-211081, 1993.

. Epstein-barr, virus-positive lymphoma in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine, Gastroenterology, vol.12210, issue.1, pp.72-79, 2002.

D. Gidrewicz, D. Lehman, S. Rabizadeh, F. Majlessipour, M. Dubinsky et al., Primary EBV infection resulting in lymphoproliferative disease in a teenager with Crohn disease Journal of pediatric gastroenterology and nutrition, Hepatosplenic T-cell lymphoma in inflammatory bowel disease: a possible thiopurine-induced chromosomal abnormality, pp.103-108, 2010.

S. Cucchiara, J. Escher, H. Hildebrand, J. Amil-dias, L. Stronati et al., Pediatric inflammatory bowel diseases and the risk of lymphoma: should we revise our treatment strategies Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease Risk factors for opportunistic infections in patients with inflammatory bowel disease Inflammatory bowel disease in children and adolescents: recommendations for diagnosis-the Porto criteria Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach Inflammatory bowel diseases, Journal of pediatric gastroenterology and nutrition. Gastroenterology. Gastroenterology. Epub Journal of pediatric gastroenterology and nutrition. Epub Biometrics, vol.10510124814113426414411, issue.753, pp.2299-301257, 1988.

J. Ezri, P. Marques-vidal, A. Nydegger, J. Bradley, S. Blume et al., Quality of life and healthcare utilisation in cystic fibrosis: A multicentre UK study. The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology The IMPACT questionnaire: a valid measure of health-related quality of life in pediatric inflammatory bowel disease Changing Crohn's disease management: need for new goals and indices to prevent disability and improve quality of life, Digestion. Journal of pediatric gastroenterology and nutrition. Epub Journal of Crohn's & colitis, vol.853510611, issue.44 2, pp.308-19557, 2002.

M. Kim, J. Lee, J. Lee, J. Kim, and Y. Choe, Infliximab therapy in children with Crohn???s disease: a one-year evaluation of efficacy comparing ???top-down??? and ???step-up??? strategies, Acta Paediatrica, vol.48, issue.Suppl 2, pp.451-507, 1992.
DOI : 10.1080/10428190701345433